Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production

Daniela P. Sequeira, Ricardo Correia, Manuel J.T. Carrondo, António Roldão, Ana P. Teixeira, Paula M. Alves

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Safer and broadly protective vaccines are needed to cope with the continuous evolution of circulating influenza virus strains and promising approaches based on the expression of multiple hemagglutinins (HA) in a virus-like particle (VLP) have been proposed. However, expression of multiple genes in the same vector can lead to its instability due to tandem repetition of similar sequences. By combining stable with transient expression systems we can rationally distribute the number of genes to be expressed per platform and thus mitigate this risk. In this work, we developed a modular system comprising stable and baculovirus-mediated expression in insect cells for production of multi-HA influenza enveloped VLPs. First, a stable insect High Five cell population expressing two different HA proteins from subtype H3 was established. Infection of this cell population with a baculovirus vector encoding three other HA proteins from H3 subtype proved to be as competitive as traditional co-infection approaches in producing a pentavalent H3 VLP. Aiming at increasing HA expression, the stable insect cell population was infected at increasingly higher cell concentrations (CCI). However, cultures infected at CCI of 3 × 106 cells/mL showed lower HA titers per cell in comparison to standard CCI of 2 × 106 cells/mL, a phenomenon named “cell density effect”. To lessen the negative impact of this phenomenon, a tailor-made refeed strategy was designed based on the exhaustion of key nutrients during cell growth. Noteworthy, cultures supplemented and infected at a CCI of 4 × 106 cells/mL showed comparable HA titers per cell to those of CCI of 2 × 106 cells/mL, thus leading to an increase of up to 4-fold in HA titers per mL. Scalability of the modular strategy herein proposed was successfully demonstrated in 2 L stirred tank bioreactors with comparable HA protein levels observed between bioreactor and shake flasks cultures. Overall, this work demonstrates the suitability of combining stable with baculovirus-mediated expression in insect cells as an efficient platform for production of multi-HA influenza VLPs, surpassing the drawbacks of traditional co-infection strategies and/or the use of larger, unstable vectors.

Original languageEnglish
Pages (from-to)3112-3123
Number of pages12
JournalVaccine
Volume36
Issue number22(SI)
DOIs
Publication statusPublished - 24 May 2018
Event6th Conference of Vaccine Technology - Albufeira, Portugal
Duration: 12 Jun 201617 Jun 2016

Fingerprint

virus-like particles
Baculoviridae
Hemagglutinins
hemagglutinins
Orthomyxoviridae
Virion
Insects
cell lines
Cell Line
insects
cells
Bioreactors
bioreactors
Coinfection
mixed infection
influenza
Human Influenza
Population
Proteins
Batch Cell Culture Techniques

Keywords

  • Bioprocess optimization
  • Hemagglutinin-based vaccine
  • Modular strategy
  • Multivalent influenza virus-like particles
  • Scale-up
  • Stable insect cells

Cite this

Sequeira, Daniela P. ; Correia, Ricardo ; Carrondo, Manuel J.T. ; Roldão, António ; Teixeira, Ana P. ; Alves, Paula M. / Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production. In: Vaccine. 2018 ; Vol. 36, No. 22(SI). pp. 3112-3123.
@article{0aa2a1aed8334e95841a540b5009dc00,
title = "Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production",
abstract = "Safer and broadly protective vaccines are needed to cope with the continuous evolution of circulating influenza virus strains and promising approaches based on the expression of multiple hemagglutinins (HA) in a virus-like particle (VLP) have been proposed. However, expression of multiple genes in the same vector can lead to its instability due to tandem repetition of similar sequences. By combining stable with transient expression systems we can rationally distribute the number of genes to be expressed per platform and thus mitigate this risk. In this work, we developed a modular system comprising stable and baculovirus-mediated expression in insect cells for production of multi-HA influenza enveloped VLPs. First, a stable insect High Five cell population expressing two different HA proteins from subtype H3 was established. Infection of this cell population with a baculovirus vector encoding three other HA proteins from H3 subtype proved to be as competitive as traditional co-infection approaches in producing a pentavalent H3 VLP. Aiming at increasing HA expression, the stable insect cell population was infected at increasingly higher cell concentrations (CCI). However, cultures infected at CCI of 3 × 106 cells/mL showed lower HA titers per cell in comparison to standard CCI of 2 × 106 cells/mL, a phenomenon named “cell density effect”. To lessen the negative impact of this phenomenon, a tailor-made refeed strategy was designed based on the exhaustion of key nutrients during cell growth. Noteworthy, cultures supplemented and infected at a CCI of 4 × 106 cells/mL showed comparable HA titers per cell to those of CCI of 2 × 106 cells/mL, thus leading to an increase of up to 4-fold in HA titers per mL. Scalability of the modular strategy herein proposed was successfully demonstrated in 2 L stirred tank bioreactors with comparable HA protein levels observed between bioreactor and shake flasks cultures. Overall, this work demonstrates the suitability of combining stable with baculovirus-mediated expression in insect cells as an efficient platform for production of multi-HA influenza VLPs, surpassing the drawbacks of traditional co-infection strategies and/or the use of larger, unstable vectors.",
keywords = "Bioprocess optimization, Hemagglutinin-based vaccine, Modular strategy, Multivalent influenza virus-like particles, Scale-up, Stable insect cells",
author = "Sequeira, {Daniela P.} and Ricardo Correia and Carrondo, {Manuel J.T.} and Ant{\'o}nio Rold{\~a}o and Teixeira, {Ana P.} and Alves, {Paula M.}",
note = "info:eu-repo/grantAgreement/FCT/3599-PPCDT/134566/PT# {"}EDUFLUVAC{"} (FP7-HEALTH-2013-INNOVATION-1, GA n. 602640. {"}Investigador FCT{"} Program (IF/01704/2014). IF/01704/2014/CP1229/CT0001). Sem PDF conforme despacho.",
year = "2018",
month = "5",
day = "24",
doi = "10.1016/j.vaccine.2017.02.043",
language = "English",
volume = "36",
pages = "3112--3123",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier Science B.V., Amsterdam.",
number = "22(SI)",

}

Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production. / Sequeira, Daniela P.; Correia, Ricardo; Carrondo, Manuel J.T.; Roldão, António; Teixeira, Ana P.; Alves, Paula M.

In: Vaccine, Vol. 36, No. 22(SI), 24.05.2018, p. 3112-3123.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production

AU - Sequeira, Daniela P.

AU - Correia, Ricardo

AU - Carrondo, Manuel J.T.

AU - Roldão, António

AU - Teixeira, Ana P.

AU - Alves, Paula M.

N1 - info:eu-repo/grantAgreement/FCT/3599-PPCDT/134566/PT# "EDUFLUVAC" (FP7-HEALTH-2013-INNOVATION-1, GA n. 602640. "Investigador FCT" Program (IF/01704/2014). IF/01704/2014/CP1229/CT0001). Sem PDF conforme despacho.

PY - 2018/5/24

Y1 - 2018/5/24

N2 - Safer and broadly protective vaccines are needed to cope with the continuous evolution of circulating influenza virus strains and promising approaches based on the expression of multiple hemagglutinins (HA) in a virus-like particle (VLP) have been proposed. However, expression of multiple genes in the same vector can lead to its instability due to tandem repetition of similar sequences. By combining stable with transient expression systems we can rationally distribute the number of genes to be expressed per platform and thus mitigate this risk. In this work, we developed a modular system comprising stable and baculovirus-mediated expression in insect cells for production of multi-HA influenza enveloped VLPs. First, a stable insect High Five cell population expressing two different HA proteins from subtype H3 was established. Infection of this cell population with a baculovirus vector encoding three other HA proteins from H3 subtype proved to be as competitive as traditional co-infection approaches in producing a pentavalent H3 VLP. Aiming at increasing HA expression, the stable insect cell population was infected at increasingly higher cell concentrations (CCI). However, cultures infected at CCI of 3 × 106 cells/mL showed lower HA titers per cell in comparison to standard CCI of 2 × 106 cells/mL, a phenomenon named “cell density effect”. To lessen the negative impact of this phenomenon, a tailor-made refeed strategy was designed based on the exhaustion of key nutrients during cell growth. Noteworthy, cultures supplemented and infected at a CCI of 4 × 106 cells/mL showed comparable HA titers per cell to those of CCI of 2 × 106 cells/mL, thus leading to an increase of up to 4-fold in HA titers per mL. Scalability of the modular strategy herein proposed was successfully demonstrated in 2 L stirred tank bioreactors with comparable HA protein levels observed between bioreactor and shake flasks cultures. Overall, this work demonstrates the suitability of combining stable with baculovirus-mediated expression in insect cells as an efficient platform for production of multi-HA influenza VLPs, surpassing the drawbacks of traditional co-infection strategies and/or the use of larger, unstable vectors.

AB - Safer and broadly protective vaccines are needed to cope with the continuous evolution of circulating influenza virus strains and promising approaches based on the expression of multiple hemagglutinins (HA) in a virus-like particle (VLP) have been proposed. However, expression of multiple genes in the same vector can lead to its instability due to tandem repetition of similar sequences. By combining stable with transient expression systems we can rationally distribute the number of genes to be expressed per platform and thus mitigate this risk. In this work, we developed a modular system comprising stable and baculovirus-mediated expression in insect cells for production of multi-HA influenza enveloped VLPs. First, a stable insect High Five cell population expressing two different HA proteins from subtype H3 was established. Infection of this cell population with a baculovirus vector encoding three other HA proteins from H3 subtype proved to be as competitive as traditional co-infection approaches in producing a pentavalent H3 VLP. Aiming at increasing HA expression, the stable insect cell population was infected at increasingly higher cell concentrations (CCI). However, cultures infected at CCI of 3 × 106 cells/mL showed lower HA titers per cell in comparison to standard CCI of 2 × 106 cells/mL, a phenomenon named “cell density effect”. To lessen the negative impact of this phenomenon, a tailor-made refeed strategy was designed based on the exhaustion of key nutrients during cell growth. Noteworthy, cultures supplemented and infected at a CCI of 4 × 106 cells/mL showed comparable HA titers per cell to those of CCI of 2 × 106 cells/mL, thus leading to an increase of up to 4-fold in HA titers per mL. Scalability of the modular strategy herein proposed was successfully demonstrated in 2 L stirred tank bioreactors with comparable HA protein levels observed between bioreactor and shake flasks cultures. Overall, this work demonstrates the suitability of combining stable with baculovirus-mediated expression in insect cells as an efficient platform for production of multi-HA influenza VLPs, surpassing the drawbacks of traditional co-infection strategies and/or the use of larger, unstable vectors.

KW - Bioprocess optimization

KW - Hemagglutinin-based vaccine

KW - Modular strategy

KW - Multivalent influenza virus-like particles

KW - Scale-up

KW - Stable insect cells

UR - http://www.scopus.com/inward/record.url?scp=85014803559&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2017.02.043

DO - 10.1016/j.vaccine.2017.02.043

M3 - Article

VL - 36

SP - 3112

EP - 3123

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 22(SI)

ER -